Adaptive Biotechnologies investor relations material

Listen to the latest call from Adaptive Biotechnologies

Adaptive Biotechnologies Corporation operates as a commercial-stage biotechnology company. It provides immunosequencing and immunodiagnostic solutions. Furthermore the company offers research and development, and customer-focused services primarily to academic, government, pharmaceutical, biotechnology, hospital/clinical laboratories, and other companies in the United States and internationally. It operates in two segments, Adaptive Diagnostics and Adaptive Therapeutics. The company's immune system platform analyzes and interprets T cell and B cell receptor sequencing data.

  • Ticker

  • Country


Dig deeper into the Adaptive Biotechnologies fundamentals on Quartr.